The company has several product candidates in various stages of clinical trials, including varespladib methyl for acute coronary syndrome, varespladib sodium for sickle cell disease, and A-623 for B-cell mediated autoimmune diseases. Anthera has license agreements with Eli Lilly, Shionogi, and Amgen for the development and commercialization of its products. Founded in 2004, Anthera Pharmaceuticals is headquartered in Hayward, California.